Global Biodefense Market 2017-2021

バイオテロ対策の世界市場2017-2021:脾脱疽、天然痘、ボツリヌス中毒症、その他

◆タイトル:Global Biodefense Market 2017-2021
◆商品コード:IRTNTR15767
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年12月1日
◆ページ数:88
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:航空・防衛
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、バイオテロ対策の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、バイオテロ対策の世界市場規模及び予測、用途別分析、主要国別分析、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。Technavio社はバイオテロ対策の世界市場が2017-2021年期間中に年平均5.41%成長すると予測しています。当レポート上に記載されている主な企業は、Altimmune、Bavarian Nordic、DynPort Vaccine Company (DVC)、Emergent BioSolutions等です。

・エグゼクティブサマリー
・バイオテロ対策の世界市場:市場概観
・バイオテロ対策の世界市場:業界の構造分析
・バイオテロ対策の世界市場:市場規模及び予測
・バイオテロ対策の世界市場:用途別分析
・バイオテロ対策の世界市場:アジア市場規模
・バイオテロ対策の世界市場:アメリカ市場規模
・バイオテロ対策の世界市場:ヨーロッパ市場規模
・バイオテロ対策の世界市場:主要国別分析
・バイオテロ対策の世界市場:成長要因
・バイオテロ対策の世界市場:課題
・バイオテロ対策の世界市場:市場動向
・バイオテロ対策の世界市場:競争状況
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About Biodefense
Biodefense is the use of medical measures to protect people against bioterrorism. It mainly applies to two different target populations, namely military combatant (troops in the field) and civilian non-combatant. The protection of food supplies and water are often considered a critical part of biodefense. Owing to the increasing threat of terrorism and bioterrorism, the risk posed by exposure to biological agents that can be used as biological weapons must be evaluated. Biological agents used in warfare may prove to be more potent than conventional weapons. In the last century, the developments made in biochemistry and biotechnology have simplified the production of such weapons. Genetic engineering can be used to create new pathogens by manipulating genes, thereby giving rise to a whole new generation of genetically modified bioweapons. Factors such as ease of production, availability of technical know-how, and the extensive accessibility of biological agents have further led to the threat of biological weapons.

Technavio’s analysts forecast the global biodefense market to grow at a CAGR of 5.41% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global biodefense market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of biodefense.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Biodefense market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Altimmune
• Bavarian Nordic
• DynPort Vaccine Company (DVC)
• Emergent BioSolutions

[Other prominent vendors]
• Acambis
• Achaogen
• Cleveland BioLabs
• Elusys Therapeutics

[Market driver]
• Growing threat of bioterrorism
• For a full, detailed list, view our report

[Market challenge]
• Lack of information about bioengineered organisms attack
• For a full, detailed list, view our report

[Market trend]
• Government initiatives
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
• Market outline

PART 05: MARKET LANDSCAPE
• Market overview

PART 06: FIVE FORCES ANALYSIS
• Five forces analysis

PART 07: MARKET SEGMENTATION BY APPLICATION
• Comparison by application
• Global biodefense against anthrax market
• Global biodefense against smallpox market
• Global biodefense against botulism market
• Global biodefense against others market
• Market opportunity

PART 08: REGIONAL LANDSCAPE
• Regional comparison
• Biodefense market in Americas
• Biodefense market in EMEA
• Biodefense market in APAC
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 11: MARKET TRENDS
• Government initiatives
• Growing collaborations and M&A

PART 12: VENDOR LANDSCAPE
• Competitive landscape
• Altimmune
• Bavarian Nordic
• DynPort Vaccine Company (DVC)
• Emergent BioSolutions
• Other prominent vendors

PART 13: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: CDC classification of bioterrorism agents
Exhibit 02: Global biodefense market: Snapshot
Exhibit 03: Global biodefense market 2016-2021 ($ millions)
Exhibit 04: Global biodefense market: Year-over-year (YoY) growth 2017-2021 (%)
Exhibit 05: Global biodefense market: Opportunity analysis
Exhibit 06: Five forces analysis
Exhibit 07: Global biodefense market share by application 2016-2021 (%)
Exhibit 08: Comparison by application
Exhibit 09: Spread of anthrax
Exhibit 10: Types of anthrax
Exhibit 11: Global biodefense against anthrax market 2016-2021 ($ millions)
Exhibit 12: Global biodefense against anthrax market: YoY growth 2017-2021 (%)
Exhibit 13: Factors responsible for making anthrax a deadly bioweapon
Exhibit 14: Types of anthrax vaccine
Exhibit 15: Global biodefense against smallpox market 2016-2021 ($ millions)
Exhibit 16: Global biodefense against smallpox market: YoY growth 2017-2021 (%)
Exhibit 17: Types of botulism
Exhibit 18: Global biodefense against botulism market 2016-2021 ($ millions)
Exhibit 19: Global biodefense against botulism market: YoY growth 2017-2021 (%)
Exhibit 20: Global biodefense against others market 2016-2021 ($ millions)
Exhibit 21: Global biodefense against others market: YoY growth 2017-2021 (%)
Exhibit 22: Global biodefense market share by region 2016-2021 (%)
Exhibit 23: Regional comparison
Exhibit 24: Biodefense market in Americas 2016-2021 ($ millions)
Exhibit 25: Biodefense market: YoY growth in Americas (%)
Exhibit 26: Biodefense market in EMEA 2016-2021 ($ millions)
Exhibit 27: Biodefense market: YoY growth in EMEA 2017-2021 (%)
Exhibit 28: Biodefense market in APAC 2016-2021 ($ millions)
Exhibit 29: Biodefense market: YoY growth in APAC 2017-2021 (%)
Exhibit 30: Key leading countries
Exhibit 31: Recent outbreaks, 2017
Exhibit 32: Competitive structure analysis of global biodefense market
Exhibit 33: Altimmune: Key highlights
Exhibit 34: Altimmune: Strength assessment
Exhibit 35: Altimmune: Strategy assessment
Exhibit 36: Altimmune: Opportunity assessment
Exhibit 37: Bavarian Nordic: Key highlights
Exhibit 38: Bavarian Nordic: Strength assessment
Exhibit 39: Bavarian Nordic: Strategy assessment
Exhibit 40: Bavarian Nordic: Opportunity assessment
Exhibit 41: DVC: Key highlights
Exhibit 42: DVC: Strength assessment
Exhibit 43: DVC: Strategy assessment
Exhibit 44: DVC: Opportunity assessment
Exhibit 45: Emergent BioSolutions: Key highlights
Exhibit 46: Emergent BioSolutions: Strength assessment
Exhibit 47: Emergent BioSolutions: Strategy assessment
Exhibit 48: Emergent BioSolutions: Opportunity assessment



【掲載企業】

Altimmune, Bavarian Nordic, DynPort Vaccine Company (DVC), Emergent BioSolutions, Acambis, Achaogen, Cleveland BioLabs, and Elusys Therapeutics


【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[バイオテロ対策の世界市場2017-2021:脾脱疽、天然痘、ボツリヌス中毒症、その他]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆